NCCIH Deputy Director on cannabis research, safety concerns and policy

  • Some evidence from well-controlled clinical trials shows that cannabis or individual cannabinoids may be helpful for various types of chronic pain; but these trials also suggest that, in some studies, the benefit may be small, and some patients may experience adverse events.
  • In addition, we know very little about the efficacy, dose, routes of administration, or side effects of commercial cannabis products available to patients through dispensaries in states that have legalised the use of marijuana.
  • The National Institutes of Health of which we at NCCIH are part supports research on the potential therapeutic benefits of cannabis or cannabinoids, including pain studies.
  • Our particular focus at NCCIH is on the potential pain relieving properties of the less-studied components of cannabis the minor cannabinoids (meaning cannabinoids other than THC) and terpenes found in the cannabis plant.

Read full article: healtheuropa.eu